nonsteroidal anti-inflammatory drugs

Death of the pressure patch has been slightly exaggerated
Death of the pressure patch has been slightly exaggeratedBest practice guidelines are just that—guidelines. They’re not religious dogma designed to herd everyone into the same line. We are rightly moving toward more evidence-based medicine, such as increased use of bandage lenses and less pressure patching in the management of corneal abrasions and erosions.
Pain-preventing NSAID welcomed by patients and cliniciansA new 0.075% formulation of bromfenac ophthalmic solution (BromSite, Sun Pharma) could provide relief from pain and inflammation associated with cataract surgery.
Purple papules pop up after antibiotic courseThe mother of a 17-year-old boy frantically brings him to the office for evaluation of an itchy, burning rash that started on his hands 1 hour ago.
NSAIDs offer potential hope for DR, AMDNonsteroidal anti-inflammatory drugs (NSAIDs) are well recognized as potent agents as they block all downstream prostaglandins, have a long history of safety and efficacy, and fare well in extended-release formulations. Recently, there has been a growing body of evidence showing they have potential in treating cystoid macular edema, said Stephen Kim, MD.
Diagnosing and managing ocular allergyOcular allergy is one of the most common ocular surface diseases seen in a primary eyecare practice. Allergic conjunctivitis (AC) often exists concurrently with rhinitis and asthma, and patients with allergic rhinitis frequently present with symptoms of AC. AC is often linked to allergic rhinitis and requires co-treatment.
Bromfenac approval brings lower-concentration formulationOnce-daily dosing delivers rapid, potent control of postoperative pain, inflammation
NSAIDs problematic for children’s kidneysNonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen given for pain or fever may cause acute kidney injury in children, even when taken in the correct dose, according to new research.